NCT03487406 - Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2) | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Ticagrelor

One 90 mg tablet, oral, twice daily for 6 months.

DRUG

Aspirin

One 75 mg tablet, oral, once a day, for 6 months.

DRUG

Placebo Aspirin

Sugar tablet to mimic Aspirin 75 mg tablet One 75 mg tablet, oral, once a day, for 6 months.

DRUG

Placebo Ticagrelor

Sugar tablet to mimic Ticagrelor 90 mg tablet. Once 90 mg tablet, oral, twice daily for 6 months.

Trial Locations (1)

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne